Vimarsana
Biggest News Aggregation in the World

Page 29 - Mark Crossley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Crossley Today - Breaking & Trending Today

Investegate |Indivior PLC Announcements | Indivior PLC: Final Results - Vimarsana News

Investegate |Indivior PLC Announcements | Indivior PLC: Final Results

Investegate announcements from Indivior PLC, Final Results

Indivior weighs secondary US listing as sales soar - Vimarsana News

Indivior weighs secondary US listing as sales soar

The group has posted a rise in annual sales today, having seen its bottom line buoyed by strong sales of its newer injectable therapy.

BUSINESS LIVE: Inflation hits 30-year high; Indivior eyes US listing - Vimarsana News

BUSINESS LIVE: Inflation hits 30-year high; Indivior eyes US listing

Consumer prices rose at the fastest annual pace in nearly 30 years last month as inflation hit 5.5 per cent, up from 5.4 per cent in December, the ONS said.

MARKET REPORT: Indivior eyes US listing as anti-opioid sales soar - Vimarsana News

MARKET REPORT: Indivior eyes US listing as anti-opioid sales soar

Shares in the FTSE250 group, which makes drugs to treat opioid addiction, shot up 14.1pc to 259.8p after boss Mark Crossley said a secondary listing on the US market was 'likely' to benefit the group.

Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants - Vimarsana News

Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants

/PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of data from a clinical pharmacology study designed to assess the ability of...